http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003212033-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7076 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7076 |
| filingDate | 2002-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dacc138082502604d45d43dba8a271bb |
| publicationDate | 2003-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2003212033-A1 |
| titleOfInvention | Weight reduction and inhibition of hypertriglyceridemia medicine containing ATP as effective ingredient |
| abstract | A weight reduction and inhibition of Hypertriglyceridemia medicine contain ATP as an effective ingredient, and more particularly to one that takes advantage of a cyclic adenosine monophosphate, Cyclic AMP) produced from the decomposed ATP in human body to promote the increase of lipase, thus to activate the metabolism and decomposition of triglyceride in the human body. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006229274-A1 |
| priorityDate | 2002-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 176.